Faga Daniel
President, CEO
Faga Daniel has filed 4 SEC Form 4 filings (17 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Mar 27, 2026.
On the most recent filing, Faga Daniel is listed as President, CEO at ANAPTYSBIO, INC. Inside the rolling window, Faga Daniel reported no open-market purchases and 4 open-market sales totaling $2.8M in ANAB. The largest disclosed transaction in the window is a sale of 17,679 ANAB shares on Mar 27, 2026, worth $1.1M.
Companies traded
Other insiders at ANAB
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.8M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Faga Daniel made?
Faga Daniel has filed 4 SEC Form 4 filings (17 transaction rows) across 1 company since 2026.
Which companies does Faga Daniel trade?
Faga Daniel has filed SEC Form 4 disclosures for 1 company, including ANAB.
When was Faga Daniel's most recent SEC Form 4 filing?
Faga Daniel's most recent SEC Form 4 filing on Tracefour is dated Mar 27, 2026.
What is Faga Daniel's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Faga Daniel is listed as President, CEO.
What is Faga Daniel's total buy and sell value in the current window?
Inside the rolling retention window, Faga Daniel bought $0 and sold $2.8M based on SEC Form 4 filings.
What was Faga Daniel's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 17,679 ANAB shares on 2026-03-27, worth $1.1M, per SEC Form 4 filings.